It has been indicated in a study that genistein could induce apoptosis in HT-29 and LoVo human colon cancer by upregulating Bax and downregulating the NF-κB pathway, thus supporting the probable application of genistein in clinical application for treating colon cancer patients [76]. This evidence concerns the gene BAX and malignant colon neoplasm.